Patents Represented by Attorney Nikaido Armstrong
  • Patent number: 4871528
    Abstract: Pharmaceutical compositions containing unit or separate dosages of 2.5 to 5 grams of reduced glutathione (GSH) and known anti-tumor agents, to be used simultaneously, separately or sequentially in anti-tumor therapy.Compounds of the invention, that can be used both in mono- or polychemotherapy, reach surprising results against tumors, thus avoiding the onset of dangerous side-effects, such as nephrotoxicity induced by cisplatinum, and increasing the long term survival rates.
    Type: Grant
    Filed: October 7, 1987
    Date of Patent: October 3, 1989
    Assignee: Boehringer Biochemia Robin SpA
    Inventors: Sergio Tognella, Michele Tedeschi, Roberto Assereto, Odoardo Tofanetti, Ennio Cavalletti